Sean D Currin, Mwawi S Gondwe, Nokthula B Mayindi, Shingirai Chipungu, Bongekile L Khoza, Stephen Tollman, June Fabian, Jaya A George, ARK Consortium
BMC Nephrol. 2021;22(1):103.
Chronic kidney disease (CKD) is predicted to increase over the next few decades and resource and access to central laboratory services is limited. Point-of-care testing (POCT) has the potential to detect markers of kidney damage, such as albuminuria. In this study, the authors evaluated the diagnostic accuracy of semi-quantitative albumin-creatinine ratio (ACR) POCT, as well as the extent of other abnormal findings in urine.
They screened 700 participants for albuminuria and found that the prevalence of albuminuria was 11.6%. The sensitivity of the POC ACR system, specificity, positive predictive value and negative predictive value was found to be 0.79, 0.84, 0.39 and 0.97, respectively. The group also reported abnormalities other than albuminuria and highlighted that some participants tested positive for haematuria, leucocytes, nitrites and glycosuria.
The authors concluded that ACR POCT has good negative predictive value and could be used to rule out albuminuria when screening for CKD. Additionally, POCT was able to detect other urine abnormalities which may reflect kidney disease or co-morbid untreated genitourinary pathology, such as urinary tract infections or endemic schistosomiasis, with important implications for CKD.
The full publication can be accessed here.
© 2023 Abt. Alle Rechte vorbehalten. Alle genannten Marken sind Marken der Abbott-Unternehmensgruppe oder ihrer jeweiligen Eigentümer.
The American Diabetes Association standards of care - 2023 guidelines provide recommendations for healthcare providers regarding cardiovascular disease (CVD) and risk management in people with diabetes. The authors highlight that atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) are leading causes of morbidity and mortality for people with diabetes, noting that simultaneously addressing cardiovascular (CV) risk factors can con...
American Diabetes Association recommendations for cardiovascular disease in diabetesenMehr Erfahren
The Kidney Disease: Improving Global Outcomes (KIDGO) 2022 clinical practice guidelines are based on a systematic review of evidence and aim to assist health care professionals with their decision making for people with diabetes and chronic kidney disease (CKD). The authors highlight that by 2045, 784 million people are estimated to have diabetes globally, of whom ≥40% will develop CKD, potentially leading to kidney failure requiring dialysis or ...
KIDGO clinical practice guidelines: diabetes management in chronic kidney diseaseenMehr Erfahren
The objective of this longitudinal cohort study was to determine the prevalence of chronic kidney disease (CKD) and associated risk factors in a rural South African population. The authors note that infectious and non-communicable disease are a substantial risk for CKD in Africa, but that heterogeneity in assessment and diagnostic criteria hamper the interpretation of prevalence.
Chronic kidney disease prevalence and risks in rural South AfricaenMehr Erfahren